Notice for Ad26.COV2.S (Janssen-Cilag Pty Ltd)
Active ingredients
Ad26.COV2.S
Sponsor
Date of review outcome
Lapse date
Type
Provisional approval
Indication
For the prevention of coronavirus disease-2019 (COVID-19) in adults greater than or equal to 18 years of age.
Therapeutic area
Infectious diseases